National MS Centrum
Melsbroek 1820
0 studies enrolling now ยท 1 studies all time
What they study most
Multiple Sclerosis, Relapsing-Remitting
Studies at this site
Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
โ Completed